The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea

Posaconazole is not superior to itraconazole for fungal prophylaxis in allogeneic blood and marrow transplantation

(2012) S B Mossad   BONE MARROW TRANSPLANTATION

Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole

(2012) Yasuaki Mino et al.   CLINICA CHIMICA ACTA

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)

(2011) M. Ruhnke et al.   ANNALS OF ONCOLOGY

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

(2011) David I. Marks et al.   BRITISH JOURNAL OF HAEMATOLOGY

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea

(2011) Dong-Gun Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Clinical Significance of Measuring the Blood Concentration of Itraconazole Oral Solution in the Field of Hematology

(2010) Sadahiko Shimoeda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring

(2009) Jodi M. Lestner et al.   CLINICAL INFECTIOUS DISEASES

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

(2009) L. Pagano et al.   HAEMATOLOGICA

Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan

(2009) Kensuke Ohta et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Population pharmacokinetics of intravenous itraconazole in patients with persistent neutropenic fever

(2008) D.-G. Lee et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS